Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/25726

Title: Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial
Authors: Mease, Philip J.
Kavanaugh, Arthur
Reimold, Andreas
Tahir, Hasan
Rech, Juergen
Hall, Stephen
Geusens, Piet P.M.M.
Pascale, Pellet
Delicha, Evie Marie
Pricop, Luminata
Mpofu, Shepard
Issue Date: 2017
Citation: ANNALS OF THE RHEUMATIC DISEASES, 76, p. 952-953 (Art N° SAT0470)
Notes: [Mease, P. J.] Swedish Med Ctr, Seattle, WA USA. [Mease, P. J.] Univ Washington, Seattle, WA 98195 USA. [Kavanaugh, A.] UC San Diego Sch Med, La Jolla, CA USA. [Reimold, A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA. [Tahir, H.] Barts Hlth NHS Trust, London, England. [Rech, J.] Univ Erlangen Nurnberg, Erlangen, Germany. [Hall, S.] Monash Univ, Melbourne, Vic, Australia. [Geusens, P.] Univ Hasselt, Hasselt, Belgium. [Geusens, P.] Maastricht Univ Hosp, Maastricht, Netherlands. [Pascale, P.; Delicha, E. M.; Mpofu, S.] Novartis Pharma AG, Basel, Switzerland. [Pricop, L.] Novartis Pharmaceut, E Hanover, NJ USA.
URI: http://hdl.handle.net/1942/25726
Link to publication: http://ard.bmj.com/content/76/Suppl_2/952
DOI: 10.1136/annrheumdis-2017-eular.1260
ISI #: 000413181402756
ISSN: 0003-4967
Category: M
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
Published version562.59 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.